Robert E Strong

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms
    Robert E Strong
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Depress Anxiety 26:273-8. 2009
  2. ncbi Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD
    Reid J Robison
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:94-102. 2010
  3. ncbi Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:103-12. 2010
  4. ncbi OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study
    Barrie K Marchant
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT, USA
    Ann Clin Psychiatry 22:196-204. 2010
  5. ncbi Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine
    Barrie K Marchant
    Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA
    Atten Defic Hyperact Disord 3:237-44. 2011
  6. ncbi Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate
    Erika D Williams
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:84-93. 2010
  7. ncbi A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    J Clin Psychiatry 68:93-101. 2007
  8. ncbi Emotional dysregulation in adult ADHD and response to atomoxetine
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Biol Psychiatry 58:125-31. 2005

Collaborators

  • Barrie K Marchant
  • Thomas J Spencer
  • Frederick W Reimherr
  • Erika D Williams
  • Poonam Soni
  • Reid J Robison
  • Corinne Halls
  • Phillip D Gale
  • Ruth Mestas
  • Scott A West
  • Dawson W Hedges
  • Lenard Adler

Detail Information

Publications8

  1. ncbi Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms
    Robert E Strong
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah, USA
    Depress Anxiety 26:273-8. 2009
    ..To more stringently test the importance of these wavelengths, bright red-light was used for the placebo (control) condition...
  2. ncbi Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD
    Reid J Robison
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:94-102. 2010
    ..This study explored the relationship between personality disorder (PD) and treatment response in a randomized, double-blind, clinical trial of osmotic release oral system (OROS) methylphenidate (MPH)...
  3. ncbi Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:103-12. 2010
    ..This study explored the relationship between the dimensions of adult attention-deficit/hyperactivity disorder (ADHD), personality disorder (PD), and adverse social adjustment...
  4. ncbi OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study
    Barrie K Marchant
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT, USA
    Ann Clin Psychiatry 22:196-204. 2010
    ..Important findings from the double-blind phase are reexamined for long-term significance...
  5. ncbi Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine
    Barrie K Marchant
    Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA
    Atten Defic Hyperact Disord 3:237-44. 2011
    ..001). Responders ultimately improved approximately 60% in attentional, hyperactive/impulsive, and emotional symptoms. Thirty-nine percent of atomoxetine double-blind non-responders became responders during open-label treatment...
  6. ncbi Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate
    Erika D Williams
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    Ann Clin Psychiatry 22:84-93. 2010
    ..Comorbidity of personality disorder (PD) and attention-deficit/hyperactivity disorder (ADHD) has been suggested in several reports. However, assessment of PD is problematic, and studies have over-relied on baseline evaluations...
  7. ncbi A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    J Clin Psychiatry 68:93-101. 2007
    ..Osmotic release oral system (OROS) methylpheni-date is a long-acting stimulant demonstrated to be effective in the treatment of children and adolescents with ADHD...
  8. ncbi Emotional dysregulation in adult ADHD and response to atomoxetine
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Biol Psychiatry 58:125-31. 2005
    ....